APELLIS PHARMACEUTICALS INC's ticker is APLS and the CUSIP is 03753U106. A total of 217 filers reported holding APELLIS PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 1.07 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2022 | $54,163,846 | -18.5% | 1,047,454 | +7.7% | 0.01% | -27.8% |
Q3 2022 | $66,454,124 | +55.4% | 972,974 | +2.9% | 0.02% | +63.6% |
Q2 2022 | $42,772,694 | +3.3% | 945,880 | +16.1% | 0.01% | +22.2% |
Q1 2022 | $41,408,372 | +36.8% | 814,965 | +27.3% | 0.01% | +50.0% |
Q4 2021 | $30,267,000 | +80.0% | 640,167 | +25.5% | 0.01% | +50.0% |
Q3 2021 | $16,815,000 | -39.8% | 510,178 | +15.5% | 0.00% | -33.3% |
Q2 2021 | $27,926,000 | +26.8% | 441,861 | -13.9% | 0.01% | +20.0% |
Q1 2021 | $22,015,000 | -41.9% | 513,050 | -22.6% | 0.01% | -44.4% |
Q4 2020 | $37,906,000 | +95.5% | 662,697 | +3.1% | 0.01% | +80.0% |
Q3 2020 | $19,393,000 | +467.2% | 642,791 | +514.0% | 0.01% | +400.0% |
Q2 2020 | $3,419,000 | -66.9% | 104,687 | -72.8% | 0.00% | -75.0% |
Q1 2020 | $10,314,000 | +522.1% | 385,000 | +413.3% | 0.00% | +300.0% |
Q1 2018 | $1,658,000 | +1.8% | 75,000 | 0.0% | 0.00% | 0.0% |
Q4 2017 | $1,628,000 | – | 75,000 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Octagon Capital Advisors LP | 2,503,059 | $170,959,000 | 29.50% |
ACUTA CAPITAL PARTNERS, LLC | 554,000 | $37,838,000 | 16.29% |
Avoro Capital Advisors LLC | 10,125,000 | $691,538,000 | 12.78% |
Sio Capital Management, LLC | 507,700 | $34,676,000 | 11.02% |
Logos Global Management LP | 1,300,000 | $88,790,000 | 10.92% |
EcoR1 Capital, LLC | 5,183,431 | $354,028,000 | 10.45% |
Cormorant Asset Management, LP | 1,478,000 | $100,947,000 | 7.06% |
Finepoint Capital LP | 266,090 | $18,174,000 | 5.98% |
Ghost Tree Capital, LLC | 275,000 | $18,783,000 | 5.27% |
Boxer Capital, LLC | 1,303,700 | $89,043,000 | 5.01% |